Annual Research Review: Child and adolescent mental health interventions: a review of progress in economic studies across different disorders by Beecham, Jennifer
Kent Academic Repository
Full text document (pdf)
Copyright & reuse
Content in the Kent Academic Repository is made available for research purposes. Unless otherwise stated all
content is protected by copyright and in the absence of an open licence (eg Creative Commons), permissions 
for further reuse of content should be sought from the publisher, author or other copyright holder. 
Versions of research
The version in the Kent Academic Repository may differ from the final published version. 
Users are advised to check http://kar.kent.ac.uk for the status of the paper. Users should always cite the 
published version of record.
Enquiries
For any further enquiries regarding the licence status of this document, please contact: 
researchsupport@kent.ac.uk
If you believe this document infringes copyright then please contact the KAR admin team with the take-down 
information provided at http://kar.kent.ac.uk/contact.html
Citation for published version
Beecham, Jennifer  (2014) Annual Research Review: Child and adolescent mental health interventions:
a review of progress in economic studies across different disorders.   Journal of Child Psychology
and Psychiatry, 55  (6).   pp. 714-732.  ISSN 0021-9630.
DOI
https://doi.org/10.1111/jcpp.12216




Annual Research Review: Child and adolescent mental
health interventions: a review of progress in
economic studies across different disorders
Jennifer Beecham
Personal Social Services Research Unit, University of Kent, London School of Economics and Political Science,
Canterbury, UK
Background: Resources for supporting children and adolescents with psychiatric disorders continue to be scarce.
Economics research can identify current patterns of expenditure, and help inform allocation of treatment and
support resources between competing needs or uses. Scope and methods: The aim was to identify the costs of
supporting children and adolescents, the economic impacts of childhood psychiatric disorders in adulthood and any
new evidence on the cost-effectiveness of interventions. An electronic search of databases (including PubMed,
Medline and Psychinfo) identified peer-reviewed journal articles published between 2005 and 2012. Findings:
Sixty-seven papers provided data on support and treatment costs now or in the future, or cost-effectiveness analyses
of services. Half the articles came from the United States. Most articles focussed on autism spectrum disorder (ASD;
23 articles), attention deficit hyperactivity disorder (ADHD; n = 15), conduct disorder (CD; n = 7), and anxiety or
depression (n = 8). Conclusion: Only 14 studies used a cost perspective wider than health care; most included
education costs (n = 11), but only five included costs to the justice system. The number of studies estimating costs to
the family has increased, particularly for children with autism spectrum disorder (ASD). In the United Kingdom,
support costs for children and adolescents with conduct disorder (CD) appear to be lower than for those with
attention deficit hyperactivity disorder (ADHD), although for the United States, the opposite may be true. Support
costs for children and adolescents with ASD may be higher than both CD and ADHD. However, there were many
differences between the samples and the methods employed making comparisons between studies difficult.
Outcomes in adulthood include negative impacts on (mental) health, quality of life, public sector services,
employment status and income. The evidence base is improving for child and adolescent psychiatric disorders,
although only one full cost-effectiveness analysis was identified since the previous review published in 2012.
However, we still do not know enough about the economic implications of support and treatment for specific
disorders. Keywords: Economic evaluations, childhood psychiatric disorders, treatment costs, support, costs,
outcomes, resources.
Introduction
Economic evaluation is increasingly becoming part of
the research landscape and integral to the evidence
base that supports services and interventions. In the
United Kingdom, for example, NICE produces guid-
ance for care providers to promote good health and
prevent ill health that has weighed up both the costs
and the benefits of treatments (www.nice.org.uk/
guidance). While economic evaluation of interven-
tions for child and adolescent psychiatric disorders
has lagged some way behind its adult counterpart,
there have been three recent reviews (Kilian, Losert,
McDaid, Park, & Knapp, 2010; Romeo, Byford, &
Knapp, 2005; Zechmeister, Kilian, & McDaid, 2008).
Each of these reviews aimed to identify and summa-
rise evaluations that explore both the costs and the
outcomes of interventions to treat or prevent mental
health problems.
This review aims to do something slightly different,
not least because theproduction rate for full economic
evaluations is low, and take a wider look at the recent
cost-related literature for child and adolescent psy-
chiatric disorders. The first aim is to identify the costs
of supporting those with psychiatric disorders. To
match the breadth of consequences that childhood
psychiatric disorders can have, themain interest is in
studies that take a broad cost perspective. Health
services can provide an important contribution to
young people’s health and mental health, but educa-
tion plays a large part in children’s lives and those
with psychiatric disorders often require additional
supports to help them attain. The justice systemmay
bear considerable costs for some adolescents and, of
course, families bear costs in terms of (co-) payments
for services, other out-of-pocket expenditures,
lost employment, and additional time spent caring.
A narrow health care perspective may miss a large
part of the full cost burden.
The costs of supporting children and adolescents
with psychiatric disorders can be far higher than for
their peers without these problems, but such disor-
ders can also lead to problems in adulthood. They can
lead to continued implications for public sector ser-
vices, peer and family relationships, and reduced
participation in the labour market. The second aim of
this article, therefore, is to explore the extent to which
these ‘downstream’ costs have been tracked or pre-
dicted. Bernfort, Nordfeldt, and Persson (2008) out-
line the data domains required to estimate societalConflicts of interest statement: No conflicts declared
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costs for childhood psychiatric disorders, illustrated
with ADHD: psychosocial and psychiatric problems,
(lower) educational achievement, substance abuse,
risky behaviour, production loss, health care and
material costs, criminality, life years lost and intan-
gibles such as impaired quality of life for themselves
and their family. The authors found that the lack of
data on longer term consequences of the disorder was
a particular challenge to such estimates.
Thefinal question to be addressedhere links closely
with theearlier reviews. Is therenewevidence fromfull
economic evaluations of interventions for childhood
or adolescence psychiatric disorders? This includes
evidence from cost-effectiveness and cost-conse-
quences analyses that, alongside costs, use in their
analysis ‘natural units’ of outcome such as a change
score from clinical scales, or depression-free days. It
also includes cost-utility analyses, which use a
health-related quality-of-life outcome such as qual-
ity-adjusted or disability-adjusted life years (QALYs,
DALYs). These studies are generally undertaken
within a randomised controlled trial, or other com-
parative design, and measure shorter term incremen-
tal costs and outcomes.
Box 1: Types of economic studies
Cost analyses
Cost of illness studies
Sums the costs incurred for treating or supporting
people with similar problems.
Cost offset studies
Compare costs incurred with costs saved with no
reference to outcomes (individual changes in clinical
status or quality of life).
Cost minimisation analysis
Compares alternatives to find the treatment option
with the lowest cost. This is justifiable where the
analysis has already shown no difference in
outcomes between the options.
Cost and outcome analyses
Cost-effectiveness analysis
Measures outcome using clinical assessments or a
single outcome such as the number of symptom-free
days. The net-benefit approach, linked to the
construction of cost-effectiveness acceptability
curves (CEACs), can show the probability that an
intervention is cost-effective for different valuations
of a unit of outcomes (improvement).
Cost-consequences
Cost and outcome results are presented for change on
each of the domains assessed in the study.
Cost-utility analysis
Values the impact of the intervention in terms of
improvements in preference-weighted health-related
quality of life, such as the Quality Adjusted Life Year
(QALY). Has the potential to allow comparisons
across diagnostic or clinical groups.
Cost-benefit analysis
Costs and outcomes are valued in the same
(commonly monetary) unit. The difficulties
associated with valuing individual outcomes in
monetary terms mean that this type of analysis is
rarely undertaken.
Source: Romeo et al. (2005)
Methods
Calculating and categorising costs
Costs arise as the result of resources being used over a
specified period: perhaps, quarterly outpatient appointments,
a number of days as an inpatient, weekly social work contacts,
or attendance at a special unit in school. Consistency in unit
cost estimations (cost per hour, per attendance, etc.) to attach
to these resource use details is important as it allows compar-
isons between studies. Both the United Kingdom and the
Netherlands have ‘standardised’ methods to estimate unit
costs based on economic theory (Curtis, 2012; Oostenbrink,
Koopmanschap, & Rutten, 2004).
Two cost initiatives were specifically aimed at helping policy
makers and providers understand cost information. For South
Africa, researchers developed a spreadsheet, attaching costs to
province-level information about population and age, epidem-
iologic data, service utilisation and associated staff require-
ments (Lund, Boyce, Flisher, & Kafaar, 2009). The analysis
estimated that the costs for minimum and full coverage of
public sector child and adolescent mental health services were
$5.99 and $21.50 per child per annum (US$PPP, 2005). The
authors report that full coverage would amount to 20% of the
Department of Health’s budget. Identifying the links between
population needs, resources (buildings and staff) and costs can
provide invaluable help in developing services. In Australia, the
National Mental Health Benchmarking project aims to help
child and adolescent mental health services understand why
their performance and costs per treatment hour and per
episode might vary (Brann, Walter, & Coombs, 2011; Furber,
Brann, Skene, & Allison, 2011). Economic theory suggests
eight reasons why costs might vary: prices paid for labour,
service location or provider sector, organisational factors,
service outputs, quality of care, patient characteristics or
outcomes (Beecham, 2006; Beecham, Green, Jacobs, & Dunn,
2009).
Once costs have been calculated, they are often categorised
in different ways. Direct and indirect costs are commonly used
terms but are not always applied consistently across research
analyses. In a pan-European cost of illness study, the authors
defined ‘direct health care costs’ as those goods and services
related to the prevention, diagnosis and treatment of a disorder
(Gustavsson et al., 2011; Olesen, Gustavsson, Svensson, Wit-
tchene, & J€onsson, 2012). ‘Direct non-medical costs’ were
defined as other goods and services related to the disorder but
provided outside the health care system, and ‘indirect costs’
included lost production due to work absence or early retire-
ment. Combining costs resulting from resources used in these
domains allows calculation of the costs of support for a child or
for a specified group of children. When these terms are used
below, they follow these definitions.
Public sector costs include services funded through the state
financing system and can cover both direct health and
nonmedical costs. Costs can also arise where parents must
pay (or part-pay) for services, where adaptations or additional
repairs have to be made in the home, or where carers lose time
from work to help the child. In the pan-European study, costs
associated with informal care (time spent by parents and other
family members) was included with direct nonmedical costs as
informal care was assumed to replace formal services. More
commonly, researchers identify family-borne costs separately.
Identifying the literature
Medline, Pubmed and Psychinfo were used to search for
peer-review journal articles published in English between
2005 and 2012. Search terms (including wildcard and trun-
cation symbols) were employed that would identify a wide
range of cost-related papers (for example, economic, cost,
cost-effective) that focussed on children and adolescents
(terms such as child, adolescent, youth, young person/people
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and by age group). The terms mental health/illness and
psychiatric disorder formed part of the search parameters, as
well as individual disorder terms. Exclusion criteria included
infants and adults, children whose parents had mental health
problems, prevention services and disorders usually seen in
adulthood. Evaluations of psychiatric medication were
excluded. Most such evaluations have a narrow payer-only
perspective (Wu et al., 2012); the majority focus on medication
for ADHD (Schlander, 2010).
An initial screen of titles and abstracts led to the removal of
886 citations that were duplicates, only considered medication
or which did not include cost data. The remaining 121 papers
were scrutinised in more detail and 64 were found to provide
data on the costs of support, now or in the future, or included a
cost-effectiveness analysis. Separate searches using ASSIA,
EMBASE, ERIC and the Cochrane Library identified a further
three papers, and ‘early view’ papers were identified in
conversation with colleagues.
Results
Most articles focussed on a single disorder, com-
monly autism (23 articles) or attention deficit hyper-
activity disorder (n = 15; see also Bishop, 2010;
Lopez-Mu~nos, Alamo, Quintero-Gutierrez, &
Garcıa-Garcıa, 2008). A further seven papers esti-
mated the costs associated with conduct disorder,
and eight focussed on anxiety or depression. Follow-
ing an overarching section, the studies for each of
these broad disorder groups are described below.
The remaining seven articles are considered in the
subsequent section, five of which relate to the costs
of eating disorders. Low numbers of papers mean
that these sections are more discursive than ana-
lytic, but the final section provides an overarching
discussion of the cost-related literature on child and
adolescent psychiatric disorders.
Where the journal articles report at least direct
health and direct nonmedical costs, results are pre-
sented in Tables 1–4. The Tables also show these
costs recalculated to their value at US$ PPP 2012.
Following the procedure used in the pan-European
study on the costs of brain disorders (Gustavsson
et al., 2011), each country’s consumer price index
was employed and the resulting figure then converted
toUS$using purchasing power parity values (PPP) for
total consumption (GDP). Although these costs are
presented at comparable price levels, some caution is
neededwhenmaking direct comparisons between the
studies. The samples in each study may not have the
samedegree of disorder severity,maybemore (or less)
representative of the full population of these children
or adolescents, may include a slightly different array
of services and, where the estimates come from
different countries, will be derived from different
service and financing systems.
The costs of child and adolescent mental health
problems
Few studies provided a national picture of the costs
of all child and adolescent psychiatric disorders. The
recent pan-European cost of brain disorders study
included only three childhood psychiatric disorders.
Total costs were estimated to be €21.3 billion per
year (€PPP, 2010) for an estimated 5,932,112 chil-
dren with attention deficit hyperactivity disorder (age
6–17 years), conduct disorder (5–17 years) or autism
spectrum disorders (2–17 years; Gustavsson et al.,
2011; Olesen et al., 2012). Indirect costs were
excluded, but direct health care costs accounted
for just 12% of the total with direct nonmedical costs
(including informal care) absorbing the major part
(88%). However, while 11 studies supported the
prevalence estimates, the authors judged just four
to be of sufficient quality to inform the cost estimates
(p758; Hakkaart-van Roijen et al., 2007; J€arbrink,
2007; Knapp, Romeo, & Beecham, 2009; Romeo,
Knapp, & Scott, 2006). Average annual costs per
child were €3,595. Annual costs were lowest for
ADHD (€781), and highest for autism (€27,261);
costs per case for conduct disorder were €1,735
(Olesen et al., 2012).
Recent estimates for the costs of all childhood
psychiatric disorders in the United States are based
on an earlier calculation (Ringel & Sturm, 2001).
Uprated from 1995 to 2007 prices, mental, emo-
tional and behaviour problems in children were
estimated to cost $247 billion per annum (O’Con-
nell, Boat, & Warner, 2009). To account for treat-
ment provided in non-(mental) health settings,
health care costs were multiplied by two based on
a study by Costello, Copeland, Cowell, and Keeler
(2007).
Recent analysis of the British Child and Adoles-
cent Mental Health (BCAMH) Surveys provides some
of the most up-to-date information on the costs of
supporting and treating mental health problems in
the United Kingdom (Snell et al., 2013; 2007–2008
prices). The BCAMH surveys are designed to have a
nationally representative sample of all British chil-
dren aged 5–15. The total mean cost for all children
with a psychiatric disorder was £1,803 per child per
annum, amounting to £1.47 billion nationally, more
than three-quarters of which was absorbed by
additional education services. In contrast to the
pan-European study, mean costs per child were
highest for those with hyperkinetic disorders at
£3,108 per annum, followed by conduct disorders
(£1,856), and the lowest costs accrued for emotional
disorders at £1,165 per annum. Costs falling to the
justice system were excluded due to poor quality
data, but can be high, particularly for those with
externalising disorders.
Both UK and US research has shown that children
and adolescents with psychiatric disorders can have
health care costs at least twice as high as their peers
with other disorders or without any disorder. These
costs derive from increased contacts with services as
well as parental absences from work (see, for exam-
ple, Ford, Hamilton, Goodman, & Meltzer, 2005;
Jones & Foster, 2009; Petrou et al., 2010). Children
who have not received any specialised treatment for
© 2014 The Authors. Journal of Child Psychology and Psychiatry. © 2014 Association for Child and Adolescent Mental Health.
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a psychiatric disorder can have nonpsychiatric
health care costs almost twice as high as their peers
without a psychiatric disorder (Wilkes, Guyn, Li, &
Cawthorpe, 2012).
For the United Kingdom, recent analysis of the
1970 British Cohort Survey has begun to identify
the longer term (age 30) economic outcomes of
childhood mental health problems (Knapp, King,
Table 2 ADHD cost studies
Authors Children & methods Cost categories included
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Table 1 Autism cost studies
Authors Children & circumstances Cost categories included
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Healey, & Thomas, 2011). Men who had childhood
antisocial conduct problems were less likely than
their peers without these childhood problems to be
economically active, but if they were working, were
likely to earn more money. Poor outcomes at ages
36–53 following adolescent conduct problems were
also found in the 1946 birth cohort (Colman et al.,
2009). Poor employment outcomes at age 30 were
also found for adults who had childhood attention
deficit disorder (ADD), and if they were working, they
Table 3 Conduct disorder cost studies
Authors Children & circumstances Cost categories included
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Interviews and administrative
data. N = 80 with conduct
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education (34%), juvenile
justice (20%)
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Table 4 Anxiety and depression cost studies
Authors Children & circumstances Cost categories included






B€ogels, Nauta et al.
(2008)
Baseline data for an RCT
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cost diaries over 2 weeks.
Clinically anxious youth
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family care
Absence from & reduced
productivity at work,
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N = 433, age 12–17 years
with depression
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were likely to be in less-skilled, lower paid jobs than
those without ADD. Compared with their peers with
no externalising behaviours, those with severe or
mild externalising behaviour in adolescence were
more likely to have symptoms of depression and
anxiety or abuse alcohol, and more likely to become
parents in their teenage years, to have left school
with no qualifications, and to experience adversity
(see also, Healey, Knapp, & Farrington, 2004).
Analysis of the WHO World Mental Health Survey
found that childhood mental health problems were
associated with early termination of education in
low- and middle-income countries, but not with
reduced household income (Kawakami et al., 2012;
Lee et al., 2009).
These large-scale analyses are rare, not least
because they require large amounts of data, ideally
longitudinal, on a wide range of topics. Their use-
fulness lies in providing a broad estimate of the
longer term health and economic outcomes and the
resources absorbed, pointing to areas where there is
a need to find ways of improving outcomes (and thus
reduce these costs), perhaps by more effective or
more easily available treatments, which will have an
impact both today and in the future.
Autistic spectrum disorder (ASD)
Introduction. Commonly diagnosed around the
time of entry to school (Mandell et al., 2010), Autistic
Spectrum Disorder (ASD) can have lifelong qual-
ity-of-life impacts on children and their families, as
well as costly support implications. Children with
autism can have severe problems with communica-
tion and social interaction and display patterns of
ritualistic and stereotypical behaviour. Intellectual
disabilities can occur in half of those with autism,
and around 30% of UK children with autism have a
clinically recognisable emotional or anxiety disorder
or an additional diagnosis of conduct disorder
(Green, McGinnity, Meltzer, Ford, & Goodman,
2005; Knapp et al., 2009). There are similarly high
rates of psychiatric comorbidity in the United States.
Analysis of the US National Survey of Children’s
Health showed that 39% of parents of children with
autism (n = 324,000) reported depression or anxiety
problems for their child, compared with just over 4%
for children without autism (Gurney, McPheeters, &
Davis, 2008; see also Peacock, Amendah, Ouyang, &
Grosse, 2012). The combination of all these factors
can lead to high costs associated with service use, as
well as for the family.
Twenty-three papers were found that explored the
costs of supporting children and adolescents with
ASD, including three that take a wide cost perspec-
tive (see Table 1) and six that identify the scope and
level of family-borne costs.
Results. Just two studies identifying the costs of
supporting children and young people with autism
were found for the United Kingdom. Using a preva-
lence of at least 1% across all ages, one estimate
suggests that there are 107,016 children and ado-
lescents age 0–17 years living with ASD in the United
Kingdom (Knapp et al., 2009). This study found no
nationally representative samples of UK children
with ASD, so estimated the costs from existing
literature and reanalysis of other research data.
Costs included housing (an estimated 1,333 children
live in residential or foster care placements, com-
monly those with additional intellectual disabilities),
as well as health, social care and education services,
and families’ out-of-pocket expenditures (2005–
2006 prices). Children were grouped by age (0–
3 years, 4–11 years and 12–17 years), with or
without intellectual disabilities (ID), and place of
residence (at home, in residential or foster care) and
national costs estimated for these groups.
• Children with ASD and ID living with families:
0–3 years, £0.86 m; 4–11 years, £739.49 m;
12–17 years, £914.69 m
• Children with ASD and ID in residential/foster
care: 0–3 years, £0.86 m; 4–11 years, £16.23 m;
12–17 years, £55.03 m
• Children with ASD but no ID living with families:
0–3 years, £1.51 m; 4–11 years, £541.49 m; 12–
17 years, £447.93 m
UK data for preschool children were rare.
A subsequent estimate for 152 children aged 2–
5 years recruited to take part in a randomised trial
of a communication intervention found total sup-
port costs of between £317 and £66,980 over
6 months (mean = £2,580; 2005–2006 prices; Bar-
rett et al., 2012). Education and child care
absorbed 45% of the costs, 41% were for commu-
nity health and social care services (80% of the
children had seen a speech and language therapist)
and hospital services accounted for just 12%. All
but one child lived at home and mean family costs
and productivity losses were estimated to be around
£3,000 over the 6-month period (range £556–
£9,611).
One US study used a similarly wide cost perspec-
tive and drew on the published literature to create a
US-based prevalence-based cohort from which life-
time costs could be calculated (Gantz, 2007). The
costs included all hospital and health care services
and equipment, child care, adult care, respite care,
home care and modifications, special education and
supported employment (2003 prices, discounted at
3%). Over a person’s lifetime, direct nonmedical
costs were three times greater than direct health
care costs, and indirect costs made up more than
half of the total. The total lifetime incremental costs
per capita were as follows:
• age 3–7, $446,203;
• age 8–12, $314,297;
• age 13–17, $285,082.
© 2014 The Authors. Journal of Child Psychology and Psychiatry. © 2014 Association for Child and Adolescent Mental Health.
6 Jennifer Beecham
Other US studies focused on health care costs,
commonly analysing large administrative or insur-
ance claims’ databases. Originally estimated at
2003 and 2004 prices, three of the four studies
show health care costs for children with ASD of
around $6,000 (Leslie & Martin, 2007; Liptak,
Stuart, & Auinger, 2006; Shimabukuro, Grosse, &
Rice, 2008). The fourth study, with data on children
taken from one health plan, shows a much lower
cost per annum of $2,757 (Croen, Najjar, Ray,
Lotspeich, & Bernal, 2006). Co-occuring intellectual
disabilities can increase costs by a factor of 2.7
(Peacock et al., 2012), but the rising health care
costs for children with autism are likely to be
because more children are treated rather than
because children receive more intensive treatment
(Flanders, Engelhart, Pandina, & McCracken, 2007;
Wang & Leslie, 2010).
Health care costs have been found to be higher for
children with ASD than for those without ASD (Croen
et al., 2006; Liptak et al., 2006; Peacock et al.,
2012; Peng, Hatlestad, Klug, Kerbeshian, & Burd,
2009; Ray et al., 2006; Shimabukuro et al., 2008)
with significantly higher numbers of visits to all
types of physicians (Gurney et al., 2008). Health
care costs have also been found to be higher for
children with ASD than for those with asthma,
diabetes or other psychiatric disorders (see, for
example, Flanders et al., 2006; Flanders et al.,
2007; Mandell, Cao, Ittenbach, & Pinto-Martin,
2006). A recent review confirmed these findings,
although not for children with depression, and also
concluded that families of children with ASD had
greater difficulties accessing services and more
unmet needs (Trenago & Cheak-zamora, 2012).
There is also evidence of a fall in the level of support
young people with ASD receive once they leave
school and should be supported by adult services
(Clarke et al., 2011; Shattuck, Wagner, Narendorf,
Sterzing, & Hensley, 2011; Singh, 2009).
Family-borne expenses are rarely estimated for
different groups of children with special needs or
disabilities (see, for example, Busch & Barry, 2007),
although six US studies have looked at these costs
for children with ASD. Family-borne costs include
those accruing for time spent in informal care
activities (although there are few data on this),
impact on employment and income, (part-) payment
for services and medications, special foods, equip-
ment and other additional household items.
Co-payments for medical care can be costly in the
United States. Liptak et al. (2006) estimated the
mean for children with ASD was $613, slightly lower
than for children with depression, but higher than
for other psychiatric disorders by a factor of seven
(1999–2000 prices). More recent US studies have
found that while 60% of parents do not make
copayments for health care, on average, these costs
are around $700 (Young, Ruble, & McGrew, 2009)
and that copayments may absorb more than 3% of
family income (Parish, Thomas, Rose, Kilany, &
McConville, 2012). Mothers of children with ASD
may also be relatively disadvantaged in the work-
place. One US study found them to be 6% less likely
to be employed and earn 56% less than mothers
of children with other health limitations (Cidav,
Marcus, & Mandell, 2012). There may also be a
higher overall impact on family income where there
is a child with ASD; 14% annual income compared to
2% for other special needs children (Montes &
Halterman, 2008).
In noninsurance-based systems, such as the
United Kingdom, copayments for services are rarer.
Family-borne costs, therefore, may be much lower.
Among their preschool sample, Barrett et al. (2012)
found that families spent an additional £227 over
6 months on adaptations and repairs to the home,
large and small equipment items, training, special
diets, travel to receive services and assessments in
abroad. Half the families in this study reported
taking time off work (on average 22 hr over
6 months).
Conclusion. There were more papers related to ASD
found in this literature search than for any other
psychiatric disorder. Although the costs in Table 1
are all presented in comparable prices, the three
studies cannot easily be compared. The data sources
are different for each study, as is the scope of costs.
The two UK studies show data over 6 to 12 months
and the US study presents lifetime costs. The net
effect of the literature is that there is a reasonably
good set of data about the scope of health care costs
in the United States, particularly hospital costs,
but less about the implications of ASD for other
provider sectors, such as education. For the United
Kingdom, the research evidence on the costs of
support for children with ASD is very patchy. For
other countries, evidence is even rarer with just one
study from Sweden of children with high functioning
autism (J€arbrink, McCrone, Fombonne, Zande0n, &
Knapp, 2005). It is, however, very encouraging to see
studies beginning to explore the various costs to
families.
Early diagnosis and early intensive treatment are
recommended for children with ASD, but we know
little about how best to use resources to intervene to
reduce some of the consequences of ASD. There is
evidence of the effectiveness of early intervention
ABA programmes (Peters-Scheffer, Didden, Korzi-
lius, & Sturmey, 2011). Potential cost-savings, if
these relatively high-cost intensive behavioural
interventions were more widely available, have been
estimated for Ontario, Canada (Motiwala, Gupta,
Lilly, Ungar, & Coyte, 2006), Texas in the United
States (Chasson, Harris, & Neely, 2007) and for the
Netherlands (Peters-Scheffer, Didden, Korzilius, &
Matson, 2012).
There are no individual-level cost-effectiveness
evaluations of ASD interventions, although a 51-cen-
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tre European study of children with pervasive devel-
opmental disorder may hold some promise. Two
hundred and eight children received an average of
30 hr of intervention per week from licensed profes-
sionals. After 3 years, 28% had a lower degree of
autism, improved speech and higher developmental
age (Darrou et al., 2010). No association between the
intensity of the intervention (a proxy for intervention
costs) and outcomes was found, and the authors
suggest that the focus for future research should be
on the type of intervention rather more than the
number of intervention hours. A new systematic
review is underway of all interventions for preschool
children with ASD (Tachibana, Green, Hwang, &
Emsley, 2012).
Attention deficit hyperactivity disorder (ADHD)
Introduction. There is considerable discussion on
the diagnosis and treatment of ADHD. It has a
worldwide prevalence of 5.3%, although this is often
considered to be highest in the United States (Pola-
nczyk, Silva de Lima, Lessa Horta, Biederman, &
Rohde, 2007). Bloom, Cohen, and Freeman (2010),
for example, report a prevalence rate of 9% from the
2009 National Health Interview Survey (12% for boys
and 5% for girls), a 2% rise on the 2006 figures (11%
for boys and 4% for girls; Bloom & Cohen, 2007).
There has been an exponential growth in published
papers on ADHD over the 25 years to 2005, nearly
half of which derive from the United States and
nearly half of which concern medication
(Lopez-Mu~nos et al., 2008). The current review
found 15 journal articles that estimated the costs
associated with ADHD, six of which adopted a wider
cost perspective (see Table 2).
Results. Pelham, Foster, and Robb (2007) reviewed
the US literature published between 2001 and 2005
and found 13 studies from which to build a cost of
illness study for ADHD, eight more than had been
identified 4 years earlier (Leibson & Long, 2003).
Most of the 13 studies focussed on health care costs
with just two estimating the costs of ADHD to the
education system, and two looking at costs borne by
the juvenile justice system. Health care costs (12
studies) were between $790 and $5,518 per child
annually (mean $2,636) including average medica-
tion costs of $459 (five studies). More than half of the
mean total annual cost of $14,576 per child com-
prised juvenile justice and crime costs. Annual
societal costs for childhood ADHD in the United
States were estimated to be $42.5 billion (2005
prices).
In the 6 years following this review, Doshi et al.
(2012) identified an additional four papers for their
literature-based (1990–2011) cost of illness model
for childhood ADHD. Health care costs were most
commonly reported (nine papers) and again showed
a wide difference in the reported estimates ($621–
$2,720 per annum). The authors based the costs of
additional educational support on three papers
(Jones & Foster, 2009; Marks et al., 2009; Robb
et al., 2011) and costs to the justice system on just
one paper (Jones & Foster, 2009).
Other studies have identified the costs of child-
hood ADHD for specific parts of the US system.
Higher inpatient costs were found for children and
adolescents with a secondary diagnosis of ADHD
than for those without (Meyers, Classi, Wietecha, &
Candrilli, 2010), high costs accrue to the school
system (Robb et al., 2011) and in the longer term, to
the justice system (Fletcher & Wolfe, 2009). When
compared with their peers without ADHD, high
service use rates among preschool children were
found for speech and language therapy, occupa-
tional therapy, physiotherapy and special education,
with the associated costs being four times higher
(Marks et al., 2009).
Analysis of the Cardiff Longitudinal ADHD Study
mirrors these raised nonhealth care costs for the
United Kingdom (Telford et al., 2013). Service-use
data were collected from parents for 143 young
people aged 12–18 years who had been treated for
ADHD 5 years earlier. The total mean cost over the
previous 12 months was £5,490 (median=£2,330,
2010 prices) with education services accounting for
76%, even though one in 10 of the young people had
already left school. NHS health care and medication
each absorbed 12% of the total costs. Using the data
from the BCAMH large survey (see above), Snell et al.
(2013) found observed mean costs for those with
hyperkinetic disorders to be slightly lower at £3,108
per annum. Neither of these studies was able to
include costs borne by justice system or the family.
Two other European studies add information on
family impacts and health care costs. A Dutch study
found that the mean direct medical costs for children
with ADHD (n = 70) were far higher than for the 35
children with other behaviour problems or the 60
children with no behaviour problems: €2,040, €288
and €177 per annum for each group respectively
(Hakkaart-van Roijen et al., 2007). Annual medical
costs for mothers attending services were also
significantly higher where they had a child with
ADHD: €728 compared with €202 (behaviour prob-
lems group), €154 (no behaviour problems). Mothers
from the ADHD group missed an average of 17 days
work per year compared with 3 and 6 days for the
other groups. In Flanders, Belgium, parents reported
their children’s use of health care, social care and
other nonmedical resources including out-of-pocket
expenses (De Ridder & Graeve, 2006). Compared
with their siblings, out-of-pocket expenditure was
more than six times higher for the child with ADHD
(€588 v. €92 per annum; 2002 prices), and public
sector costs were twice as high (€779 v. €371 per
annum).
Where medication costs were separately identified,
they comprised around 20% of health care costs.
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Global spending on ADHD medication grew ninefold
to US $2.4 billion between 1993 and 2003. This
spending growth was concentrated in developing
countries with the United States absorbing over 80%
of the global market (Scheffler, Hinshaw, Modrek, &
Levine, 2007), although one study found that the
United States may pay higher prices for this medi-
cation than other countries (Lang, Scheffler, & Hu,
2010). A systematic review of papers published
between 1990 and 2011 found ADHD medication to
be more cost-effective than no treatment, placebo,
behavioural therapy or community care, but insuf-
ficient evidence on the relative cost-effectiveness for
different groups of children and adolescents, or for
the different pharmaceutical preparations (Wu et al.,
2012). Findings from the cost-effectiveness analysis
of the Multimodal Treatment Study of Children with
ADHD (Jensen et al., 2005) were included in that
2012 review. Other analysis of these data suggests
that as children’s needs rise, behaviour therapy with
or without medication may cost more today, but may
generate higher cost-savings in the future (Foster,
Jensen et al., 2007).
Conclusion. Table 2 shows that the direct health
care costs estimated across four countries
vary widely, from US$ PPP $660 to $3,140 (both
estimates are from US studies). Among the European
countries, the UK studies estimate both the lowest
and the highest health and mental health care costs.
These two studies have a different sampling frame:
a longer term follow-up of a clinical/research sam-
ple (Telford et al., 2013) and a national survey
(Snell et al., 2013), but include a similar scope of
costs.
Education costs are estimated for four studies
shown in Table 2, and for three are around $5,000
per annum (US$ PPP). Crime-related costs, derived
from existing literature, were estimated in just two of
these studies. The lower figure (Doshi et al., 2012)
uses data from two earlier studies, one of which
includes only the costs to the justice system. The
higher figure includes victim costs (Pelham et al.,
2007; p719). As with studies estimating the cost of
ASD, most analyses focus on health care costs (see
text) with just one recent US article from the Fast
Track study additionally incorporating costs to the
education (32%–57% of total costs over the age
groups) and justice (5%–25%) systems (Jones &
Foster, 2009).
Studies looking at the relative cost-effectiveness of
treatment options are rare. Six studies including a
nonmedication treatment option were included in
Wu et al. (2012), only two of which were published
since 2005 (Foster, Jensen et al., 2007; Jensen
et al., 2005). Both these analyses use the Multi-
modal Treatment Study, which evaluated three
treatment modes. The main cost-effectiveness
results show that medication treatment dominated
community care plus behavioural therapy and
behavioural therapy alone (Jensen et al., 2005).
This literature search revealed no other articles
reporting cost-effectiveness analyses of nonmedica-
tion ADHD treatments.
Conduct disorder (CD)
Introduction. Conduct disorder (CD) is another
relatively common childhood psychiatric disorder.
With a prevalence rate of about 5%, it is likely to
persist into adulthood in about half of all childhood
cases. CD is characterised by repetitive patterns of
antisocial, aggressive or defiant conduct. Behaviours
such as lying, bullying, threatening or intimidating
others are common, as is truanting from school.
Preschool diagnosis is common; a short screener
completed by teachers can identify at-risk kinder-
garten children (Jones, Dodge, Foster, Nix, & Con-
duct Problems Prevention Research Group, 2002).
The literature search identified a small cluster of cost
papers based around the US Fast Track study, two
separate UK studies, and two reviews of the eco-
nomic evidence for parenting programmes and CD.
Table 3 shows the support costs derived from four
studies where costs to nonhealth care sectors have
been estimated.
Results. The Fast Track Study has provided some
of the most up-to-date US data on the costs of
conduct disorder. Recruitment for the study began in
1990 and continued for 5 years, and the study
makes use of interview and administrative data to
calculate a wide range of support costs (2000 prices;
Foster, Damon, & Jones, 2005). Costs over school
years 7–13 were far higher for children with CD
(n = 59), than for those with oppositional defiant
disorder (n = 78), those within one criterion of being
diagnosed (n = 40) or those with no behaviour prob-
lems (n = 488). School costs accounted for the larg-
est proportion, followed by juvenile justice costs
(20%). Cumulative costs by school year 13 for those
with CD amounted to over $70,000 more than for
those with no behaviour problems. By linking the
Fast Track intervention costs with its impact on
conduct disorder, subsequent analysis found that
such expensive interventions are likely to be
cost-effective if they can be targeted on those who
will be costly to society when left untreated (p1289;
Foster, Jones, & the Conduct Problems Prevention
Research Group, 2006).
Two studies provide some insights into the high
costs of conduct disorders in the United Kingdom.
Table 3 shows that both Romeo et al. (2006) and
Clark, O’Malley, Woodham, Barrett, and Byford
(2005) include a wider range of cost categories than
do Snell et al. (2013). Persistent antisocial behaviour
is a core feature of conduct disorder, and total support
costs for 80 children, all assessed as being in the
worst 1% for disruptive behaviour, were between £49
and £19,940 per annum, around a mean of £5,960
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(2002–2003 prices; Romeo et al., 2006). Service costs
(£1,277) fell mainly to the health care system and
education, but the nonservice family-borne costs
(time taken off work, additional time spent preparing
meals, shopping, cleaning, etc.) far outweighed the
service-related costs at 78% of the total. Greater
severity of behaviour problems raised costs but
explained only 7% of the cost variation.
In the secondUK study, local services were asked to
identify their ‘most concerning youth’ (Clark et al.,
2005). Just five of the 56 young people had no
psychiatric diagnosis and 53% were diagnosed with
conduct disorder. In contrast to the first study, more
than half (60%) had lived in specialist facilities away
from home over the year for which costs were calcu-
lated. Mean annual public sector costs were therefore
much higher at just over £52,000 per year (£1,017 per
week, 2000–2001 prices) with half accruing to social
care services, anda third to education.Costs tohealth
care and the justice systemwere surprisingly low (5%
of total costs each), in part due to highuse of specialist
nondomestic accommodation with relatively high
levels of staffing (52% of total costs). Costs were
significantly higher for younger children, those living
away from home, showing inappropriate sexual
behaviour and if the child was from a white ethnic
background.Measures ofmental health needs (sever-
ity) did not influence costs.
The high costs of supporting children and adoles-
cents with conduct disorder and the likely down-
stream implications (see above, Knapp et al., 2011)
suggest that early treatment is key to reducing costs.
An economic case has been made for a number of
childhood interventions in the United Kingdom:
parenting programmes, school-based social and
emotional learning programmes, school-based inter-
ventions to reduce bullying, and early detection and
intervention for psychosis (Knapp, 2011). Evi-
dence-based parenting programmes, for example,
may be cost-saving to the public sector within
5–8 years, and save £16,450 per family over
25 years (see also, Bonin, Stevens, Beecham, Byford,
& Parsonage, 2011). Empirical analyses of 20 years
of US trials (n = 459) supported ‘stacking’ parent,
teacher and child components of the Incredible Years
programme as a means of providing cost-effective
(intervention costs only) treatment for behaviour
problems in children age 3 to 8 years old (Foster,
Olchowski, & Webster-Stratton, 2007).
Implementation is key to both shorter term
cost-effectiveness and achieving the predicted sav-
ings for early interventions. However, there is a
paucity of evidence on whether parenting pro-
grammes can be rolled-out and run effectively in
routine practice, how to encourage parents to com-
plete the course, how to identify and target groups
of parents likely to benefit, how to engage hard-
to-reach populations and whether the programme
will engender benefits into adulthood (Bonin et al.,
2011; Stevens, 2012).
Conclusion. In the United Kingdom, support costs
for children with CD appear to be lower than for
children with ADHD (see Tables 2 and 3; Snell et al.,
2013). For the United States, the Fast Track study
suggests that the support costs for children with CD
might be higher than for those with ADHD, and that
public sector costs for children with both ADHD and
CD are twice as high as for ADHD alone (Jones &
Foster, 2009). However, when looking at the data in
Table 3, it is important to take each sample’s age
range into acount. As Foster et al. (2005) note, costs
linked to crime increase as children age, and thus
were less relevent in the Romeo et al. study (2006;
children ages 3–8 years) and they were excluded
from the analyses undertaken by Snell et al. (2013)
even though the age range was 5–15 years. The
analysis by Clark et al. (2005) sits slightly apart from
the other three papers as only half the young people
were diagnosed with conduct disorder. Moreover,
much higher use of costly highly supervised non-
hospital residential establishments than in any of
the other studies raised total costs considerably.
Notably, there is far less attention paid to costs
borne by families with a child with CD than for
families including a child with ASD or ADHD.
Intervening early, as symptoms of conduct disor-
der become apparent, is recommended and has been
shown to save costs downstream. The economic
evidence to support parenting programmes for CD
is positive but limited (Charles, Bywater, & Edwards,
2011), and as with ADHD, we know little about the
longer term outcomes.
Anxiety and depression
Introduction. There are fewer articles reporting
cost-related aspects of depression and anxiety than
for the three disorders considered so far. Lynch and
Clarke (2006) found only five articles containing data
up to April 2005, four from the United States and one
from the United Kingdom. They concluded that there
was insufficient evidence to estimate the economic
burden of depression in children and adolescents.
Today, the picture is only a little more encouraging.
The search identified only one article providing a cost
of illness estimate for young people with anxiety and
two estimating the costs of supporting those with
depression (see Table 4). Three studies describing
the impacts of depression into young adulthood were
also identified, as well as four cost-effectiveness
evaluations published since 2007, two of which
came from the same study.
Results. A Dutch cost of illness study focused on
118 anxious young people aged 8–18 who were
referred to community mental health services. Mean
annual costs per child were €2,748 per annum for
direct health care, direct nonmedical care, and
indirect and out-of-pocket expenses (2003 prices;
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Bodden, Dirksen, & B€ogels, 2008). Inpatient care,
day treatment, and parental productivity losses each
contributed around a quarter to the total costs. The
annual national cost was calculated to be
€20,294,000. These data formed the baseline of a
cost-effectiveness study, the results of which
favoured individual cognitive behaviour therapy
(CBT) over family CBT 1 year after treatment, mainly
due to slightly (but not statistically significant)
improved outcome scores (Bodden, Dirksen, B€ogels,
Nauta et al., 2008). In the analysis of the British
Birth Cohort Surveys, Knapp et al. (2011, see above)
found childhood anxiety problems to be associated
with lower income at age 30 but not with being
employed or occupational status.
The costs of supporting adolescents with depres-
sion in the United States were also estimated using
baseline data from a trial (TADS, see below). Service
use data were collected from individual participants
and their families over a 3-month period (Domino,
Burns, Mario et al., 2009). With the wide population
coverage of andministrative and insurance-based
databases, such an approach is rare in the United
States, but does mean that a broad public sector
prespective can be taken – here, health and mental
health care, social care, education and the justice
system – as well as family costs. Annual costs per
family, estimated by multiplying the reported
3-month cost by four, were $1,124 (2003 prices).
Major depressive disorders (MDD) in childhood
have both health and economic impacts in adulthood,
as findings from four recent studies show. A longitu-
dinal study in the United States showed that while
controlling for current depression (at age 20), those
diagnosed with depression at age 15 had higher
health care use, poorer self-perceived general health
and increased levels of work impairment (Kee-
nan-Miller, Hammen, & Brennan, 2007). Smith and
Smith (2010) also highlighted the link between child-
hood psychological conditions and physical health in
adulthood. Their analysis of the US Panel Study of
Income Dynamics showed that after controlling for
physical ailments in childhood and family members,
and neighbourhood characteristics, both educational
achievement and family income were lower for those
who had a childhood psychological condition.
Similar findings come from analysis of data on a
cohort of young adults born in New Zealand in 1977
and participating in the Christchurch Health and
Development Study (Fergusson, Boden, & Horwood,
2007). Thirty-five per cent of the cohort met the
criteria for at least one episode of major depression
between 16 and 21 years old. By age 21–25, and
after adjusting for family and personal characteris-
tics, increased frequency of depressive episodes was
significantly associated with poorer mental health
outcomes (depression, anxiety and suicidal behav-
iour), poorer educational achievement, and a greater
likelihood of being dependant on welfare payments
and being unemployed.
Information about cost-effective interventions in
childhood, which may mitigate poor child and adult
outcomes, is rare with just two recent studies, each
comparing cognitive behavioural therapy (CBT) and
medication.
The UK-based trial randomly assigned 208 ado-
lescents (11–17 years) to clinical care plus additional
selective serotonin reuptake inhibitors (SSRI, mainly
fluoxetine) or clinical care plus SSRIs plus 19
sessions of CBT (Byford, Barratt, Roberts, Wilkinson
et al., 2007). Costs across the public sector were
measured, plus travel costs and productivity losses
for the intervention sessions (2003–2004 prices).
At 28 weeks, there were no significant differences in
clinical outcomes, QALYs (from the EQ-5D) or costs.
The cost-effectiveness analysis suggested that the
probability of SSRI+CBT being more cost-effective
than SSRIs alone is very small.
However, the US-based trial for adolescent depres-
sion (TADS) came to a different conclusion. This RCT
compared fluoxetine, CBT, and a combined inter-
vention of CBT and fluoxetine in 327 adolescents
age 12–18. Depression-free days were estimated and
costs included the intervention and health care,
caregiver reports of other health care, school-based
counselling, criminal justice and social care ser-
vices, and caregiver time and travel for the inter-
vention (2003 prices). At 12 weeks, the results
favoured treatment by fluoxetine alone (Domino
et al., 2008), but at 36 weeks, the analysis showed
SSRI+CBT to be the more cost-effective option
(Domino, Burns, Silva et al., 2008; Domino, Foster
et al., 2009).
Conclusion. Comparing the 2012 US$ costs for
supporting children and adolescents with depres-
sion (two studies; see Table 4) with costs shown in
the earlier tables, this disorder appears to be
absorbing fewer health and mental health care
resources, and is less costly to the education system.
Direct health care costs for anxiety (one study) are
closer to costs for ADHD and CD. However, these
disorders are less well served by cost-related
research than ASD, CD or ADHD, although both
have implications for poorer adult health and quality
of life. The question of how best to use resources to
treat these disorders in childhood also remains
unanswered, even when considering medication
(see also, Schlander, 2010; p2455). This absence of
research evidence hampered provision of value for
money advice to health policy makers in Australia
and the authors had to draw on adult studies for
some parameters in their analysis of childhood
depression (p. e724, Mihalopoulos, Vos, Pirkis, &
Carter, 2012).
Other disorders
Introduction. The four disorder groups considered
so far absorb the majority of the current literature on
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cost-related research. In this section, cost papers
relating to eating disorders (five journal articles),
psychosis (two articles) and bipolar disorder (one
article) are summarised.
Results. A recent UK estimate for the health care
costs associated with eating disorders is
£80 m-£100 m, accompanied by GDP reductions of
between £0.23bn and £2.9bn (Pro Bono Economics &
beat, 2012). Baseline data from a randomised con-
trolled trial showed that the public sector costs
associated with supporting 85 young people with
bulimia nervosa and eating disorder not-otherwise
specified (EDNOS) were around £700 over 3 months
(2003–2004 prices; Schmidt et al., 2007, 2008).
Subsequent family therapy was found to cost almost
twice as much as self-guided care, but 12 months
later, there was no difference in either outcome
(bingeing) or support costs between the two inter-
vention groups, although public sector costs had
reduced for both groups (Schmidt et al., 2007) and
those with EDNOS responded less well to treatment
(Schmidt et al., 2008).
An internet-delivered intervention for young peo-
ple with bulimic symptoms showed positive out-
comes, some reduction in service contacts and
reduced family expenditure (Pretorius et al., 2009).
Again incorporating newer technologies, telemedi-
cine CBT for young people with bulimia nervosa
living in the United States generated similar out-
comes for young people as face-to-face CBT but at a
reduced cost (Crow et al., 2009). Using a narrow
cost perspective (initial evaluation, laboratory tests
and psychotherapy visits), the cost per recovered
(abstinent) person was $9,325 for usual care and
$7,300 for telemedicine (2005 prices). A recent
review suggests that tele-psychiatry has the poten-
tial to be a useful treatment option but that
questions remain about confidentiality, legality,
reimbursement and cost-effectiveness (Paing et al.,
2009).
The final study of eating disorder services com-
pared inpatient and outpatient treatment and gen-
eral CAMHS and specialist eating disorder services
in the United Kingdom. There were no outcome
differences between the treatment options for these
adolescents with anorexia nervosa (n = 167), but
higher costs for those using generalist CAMHS
services, mainly because of increased hospital
admissions (Byford, Barratt, Roberts, Clark et al.,
2007). Specialist outpatient care proved to be the
‘dominant’ option when comparing incremental
cost-effectiveness ratios, supporting the current
clinical guidelines for England.
Turning to interventions for psychosis, two mod-
elling studies suggest that a change in the way
services were delivered to children and adolescent
with psychosis would save money. Using a narrow
cost perspective (inpatient care and the early inter-
vention service), a UK-based decision-analytic model
identified that cost-savings of £4,814 per young
person over 6 months were an early intervention
service to replace standard care (2010 prices;
McCrone et al., 2013). Wong et al. (2011) used a
matched group design to show that outcome were
similar for a new early assessment service in Hong
Kong (n = 65 young people), but offered 35% savings
per one point improvement on a clinical scale
(PANNS) over the previous service. Finally, one US
study on bipolar disorder among children and ado-
lescents (n = 4,973) found the annual hospital and
pharmacy costs to equal that for adults; 71% of the
total was for mental health care with psychotropic
medications absorbing about a third of that cost
(Dusetzina et al., 2012).
Conclusion. It is difficult to formulate any overall
conclusions from such a small disparate set of
studies. However, most of these are recent publica-
tions suggesting that, although lagging behind
research for other disorders, this may represent the
start of an improved evidence base.
Discussion
The first JCPP review of economics and child and
adolescent mental health was published more than
15 years ago (Knapp, 1997) and since then, there
have been three reviews of economic evaluations in
child and adolescent mental health published in
peer-review journals. Looking at the literature from
1966 to 2003, Romeo et al. (2005) identified 21
studies that measured both costs and outcomes,
although seven did not report individual-level out-
comes; nine of these studies were published after
1996. Seven of the 14 studies published between
1992 and 2004 and discussed in a review of mental
health promotion and mental illness prevention
focused on children and adolescents (Zechmeister
et al., 2008). A third systematic review of economic
evaluations of interventions published between
2001 and 2009 found 12 studies using primary
data and seven that developed simulation models
(Kilian et al., 2010). The general conclusion from
these reviews was that although the number of
economic evaluations was rising, studies suffered
from small sample sizes, short time horizons and
narrow cost perspectives. For simulation models,
there was a lack of clarity in methods and too
many assumptions made in the absence of sup-
porting evidence. The most recent of these reviews
(Kilian et al., 2010) suggests that there is still a
continuing dependence on a narrow payer-only
perspective, but that the quality of papers is
improving.
In their review of the benefits and costs of preven-
tion (papers published up to 2007), O’Connell et al.
(2009) arrive at a similar conclusion. They also
suggest that to develop the limited evidence base,
guidelines might improve the quality of economic
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evaluations, and help ensure that an economic
evaluation always accompanies an effectiveness
study. Four other focussed reviews of economic
evaluations have been published since 2009: two
considered the economic evidence for parenting
programmes to intervene in childhood behaviour
problems (Charles et al., 2011; Stevens, 2012); and
two reviewed studies of medication (Schlander,
2010; Wu et al., 2012). All four of these reviews
found full cost-effectiveness analyses to be rare and
methodological problems to be common.
This review has collated the data from studies
published in peer-reviewed journals since 2005 with
the aim of identifying support costs, adult conse-
quences, and cost-effective child and adolescent
interventions. The wider aims of this paper led to
the overlap in dates with the earlier reviews. In this
discussion, the focus is on studies published from
2009, including two identified in the most recent
review (Kilian et al., 2010).
From 2009 to 2012, this review identified seven
studies of costs and outcomes (analyses concerned
only with medication are excluded), including three
modelling studies, plus five analyses looking at the
longer term consequences of childhood mental
health problems. Seventeen papers reported the
costs of treating and supporting children with psy-
chiatric disorders, predominantly focussing on
health care costs. Studies using data from the United
States (n = 39) and the United Kingdom formed the
majority and there were just three articles concern-
ing low- or middle-income countries (Kawakami
et al., 2012; Lee et al., 2009; Lund et al., 2009).
Limiting the search to English language papers may
have contributed to this bias; however, Kilian et al.
(2010) revealed a similar geographical spread but
had no language restrictions, as long as there was an
English title on the database. This review identified
just one additional paper from Germany that had an
English title and abstract (Schlander, Trott, & Sch-
warz, 2010).
Notably, the search identified only one full
cost-effectiveness study published since 2009, eval-
uating medication and CBT for children and adoles-
cents with depression. The previous service use and
cost paper and shorter term cost-effectiveness eval-
uation from this study added to a very limited
evidence base on support and interventions for
adolescent depression in the United States. The
UK-based cost-effectiveness evaluation of medica-
tion and CBT fulfils a similar role (Byford, Barratt,
Roberts, Wilkinson et al., 2007). Two cost-effective-
ness studies examining similar treatments for sim-
ilar conditions are to be welcomed, but this also
serves to highlight gaps in the current evidence base
and the difficulties of linking individual studies. In
the first place, medication and CBT are only two of a
range of treatments available; for example, no
cost-effectiveness analyses were found in a review
of psychotherapy interventions for depressed chil-
dren and adolescents (Watanabe, Hunot, Omori,
Churchill, & Furukawa, 2007). That is not to say
that these treatments are not more (or less)
cost-effective than other options, just that as yet
there is no evidence either way. In the second place,
these two studies of medication and CBT are not
fully comparable because although the methods are
robust and clearly stated, the cost perspective is
different, the studies use different outcome mea-
sures, there are potential differences in the inter-
vention, etc. And third, there are differences between
the countries’ health care organisation and financing
systems; these make it very difficult to compare
cost-effectiveness findings between countries. To
come to a definitive view on relative cost-effective-
ness, data from many more trials are needed for
meta-analysis or analysis of combined individ-
ual-level data sets (see, for example, Bower et al.,
2003; Foster, Jensen et al., 2007). This review also
uncovered five trial protocols that included an eco-
nomic evaluation, although none comparing medi-
cation and CBT. Other trials, of course, may well be
underway, but not have published their protocol in
the areas searched.
Ten articles published since 2009 report the costs
of supporting or treating groups of children and
adolescents with various disorders, one of which
drew on existing literature. Cost of illness studies
need good quality diagnostic or epidemiologic infor-
mation and details of resources (services) used, as
well as (unit) costs for those services. Each of the
studies reported here drew on robust diagnostic
instruments to ensure that the appropriate popula-
tions were included. However, the World Health
Organisation found there was no meaningful epi-
demiologic information for about two thirds of the
192 countries worldwide, yet up to 20% of children
and adolescents may suffer from a disabling mental
illness (Belfer, 2008).
Among the nine data-based cost of illness studies,
there are, broadly speaking, two types. On the one
hand, there are costs data derived from larger
surveys, routine data collections or claims’ data-
bases (four papers); on the other are costs calculated
from studies where primary, usually prospective,
data are collected for a specific sample (five papers).
The division is not always as clear-cut as this of
course, but both broad methods have their positive
attributes, and both have their limitations. For
example, large survey and databases are more likely
to provide a representative sample of children, but
they also tend to be more limited in the scope of
resource use that is measured and thus have a
narrower cost perspective. Commonly, these studies
focus on health care service use and costs, although
databases for education and justice systems have
also proved useful.
Primary data tends to come from smaller, often
prospective, studies. They often include more
detailed information on a wider range of service and
© 2014 The Authors. Journal of Child Psychology and Psychiatry. © 2014 Association for Child and Adolescent Mental Health.
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supports (although this can be for a closely specified
sample) allowing a broad perspective to be presented
in the cost calculations. Findings from these studies
show that for children and adolescents with psychi-
atric disorders, it is very rare for the health sector to
bear a large proportion of total support costs. Where
all public sector costs are considered, it is common
for the largest proportion to fall to the justice system
in studies of adolescents and to the education system
for younger children. However, where a societal
perspective is taken and family-borne costs are
included, by far the largest cost impact is accounted
for by the value of work absence. Assessing the
extent of support received from informal care (time
parents spend caring in particular) is particularly
difficult in evaluations of children’s services – when
does parental care end and additional support due to
the disorder begin? There are additional questions
about measuring the impact of a child’s disorder on
the family. For example, should the costs of addi-
tional services used by parents and siblings be
included? When estimating the costs of parental lost
productivity, should the study also look at how the
child’s problems changed parents’ employment tra-
jectories?
There are also differences in the way data on
service use are collected: claims’ databases or man-
agement information systems collate data from ser-
vices, other studies (surveys, smaller prospective
studies) often rely on parents’ recall, and occasion-
ally interview the young person. Comparisons
between the two methods have shown mixed results
with greater concordance for larger items (such as
hospital care) and for shorter time spans. For all the
above reasons, it is very difficult to compare the
costs of supporting or treating children across stud-
ies. Moreover, the studies discussed in this review
have such an array of participant needs, perspec-
tives and approaches to (unit) costs that simple
comparisons can confuse rather than clarify. One
common finding was that almost all studies found
cost data to be highly skewed across the sample.
Most children and adolescents have little contact
with services (low costs), and in any sample, there
are usually a few participants who use services
intensively and generate high costs. Mean costs
provide useful information for planners, but cost
variation analyses can help providers manage their
service appropriately and can highlight equity issues
(see, for example, Howell & Teich, 2008). Where such
analyses have been undertaken, it is rare for the
proportion of cost variation statistically ‘explained’ to
reach more than 30%, but there are some cost
associations that appear reasonably frequently: age,
severity of condition, comorbidity, whether a com-
munity or clinic sample and some family character-
istics related to deprivation.
Three of the papers published since 2009 report
adult economic outcomes for childhood disorders.
Studies that estimate longer term morbidity and
economic outcomes commonly use longitudinal
studies or population surveys from which certain
groups are selected. For child and adolescent mental
health problems, subsequent adult impacts can
generally be seen in their poorer health, quality of
life and family life, as well as negative impacts on
employment status and income.
Findings such as these can indicate where inter-
vention in childhood and adolescence is needed to
try to avert poor outcomes, whereas modelling stud-
ies (four since 2009) more commonly aim to show
that investing money today in particular services
will save money to the public purse or society in
the future. Such models are often developed because
there is not enough evidence from primary
research to draw firm conclusions about longer
term cost-effectiveness. Generally speaking, in the
papers described here, methods were clearly stated
and data sources identified, although the cost
perspective was very narrow in two of the studies.
However, the challenges in generating these savings
in the real world are not necessarily to do with
putting these services in place, because the models
are usually based on innovative services already in
existence. The challenges are more about the ability
to predict which individuals are ‘at risk’ (need the
services) and will benefit most, targeting the service
on these groups, and in ensuring that those who
attend receive an effective ‘dose’ of the service.
This paper has attempted to do something rather
different from earlier reviews of economic evalua-
tions, which have assessed studies that measure
both costs and outcomes of child and adolescent
mental health interventions. As well as identifying
these cost and outcome analyses, this paper aimed
to pull together the information on the costs of
support and treatment of child and adolescent
psychiatric disorders and their longer term (adult-
hood) costs. Measures commonly employed to assess
the quality of studies, such as the BMJ guidelines for
economic evaluations, are less helpful because the
intention is to range across different types of eco-
nomic studies. Generally speaking, this has brought
forth a slightly more rosy view of the quantity and
quality of the economic studies. Taken overall, these
studies have reported their methods and cost per-
spective in a good depth of detail. Some studies
continue to use a narrow perspective, but others are
broadening the view to include nonhealth care
providers. They are also beginning to highlight the
high cost to parents – not just due to absence from
work but also the costs that families bear for
providing additional care and support to a child with
mental health problems. Analytic approaches are
generally well described, although lack of space
means that the details cannot be replicated here.
Similarly, many papers explore cost or other varia-
tions within a population sample; these complex
analyses generate far finer level of results and
findings than would fit into this article.
© 2014 The Authors. Journal of Child Psychology and Psychiatry. © 2014 Association for Child and Adolescent Mental Health.
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Conclusion
The demands for economic evaluation remain the
same today as when described 15 years ago (Knapp,
1997). Prevalence of child and adolescent disorders
continues to grow whether in real terms – perhaps
because of wider cultural, social or economic
changes – or due to improved detection (Collishaw,
Maughan, Goodman, & Pickles, 2004; McClellan,
Bresnahan, Echeverria, Knox, & Susser, 2009;
McCrone, Dhanasiri, Patel, Knapp, & Lawton-Smith,
2008; Sourander et al., 2005). Wider economic
pressures and government cutbacks are a major
challenge for commissioners and service providers in
the United States and almost every European coun-
try. The policy and practice backdrop is one of
continually developing health care systems and
markets in which there is an increasing need to
show value for money. This means that there is still a
need for better economic evidence to inform policy
and practice.
There is no doubt that the evidence base is improv-
ing and while the articles published post-2005, and
particularly the post-2009 articles, have provided
better methodological information, this should not
lead to complacency. The publication rate for cost-re-
lated articles in child and adolescent psychiatry is
about10per year since2009.Althoughonly ahandful
of these wouldmeet the criteria for the earlier reviews,
this is good progress. However, when looking through
the lens of specific disorder groups, the resulting
evidence base is perhaps less encouraging. For
example, it has only been possible to identify more
than a handful of published journal articles for four
disorders: autismspectrumdisorder, attentiondeficit
hyperactivity disorder, conduct disorder and depres-
sion. Moreover, most of the studies, including those
that identify impacts in adulthood, refer to the US or
British context. There is, therefore, little additional
information to help address the questions identified
in 1997: we still do not know enough about what
support and treatment should be provided; when,
where or to whom it should be provided; or how
support and treatment should be provided. Despite
the increase in cost-related studies and the progress
made over the last decade, a considerable amount of
research is still needed before there is a sound
evidence base to inform decisions on how best to use
scarce resources to support and treat children with
mental health problems.
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Key Points
• There are far fewer economic studies for child and adolescent psychiatric disorders than for adult disorders.
Earlier reviews have found the quality of studies that combine costs and outcomes to be poor.
• Costs falling to nonhealth agencies such as those providing social care, education, justice and family costs can
be high, but are rarely assessed. This wide perspective matches the breadth of consequences that childhood
psychiatric disorders can have.
• High nonhealth costs in childhood and poor economic outcomes in adulthood make a strong case for
increased investment in treatment for childhood psychiatric disorders.
• Many more good quality economic studies, including cost-effectiveness analyses of new and existing
interventions, are required to provide a sufficient body of evidence to help commissioners and providers make
decisions about resource allocation.
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